Table 3. Relationship between immune-related adverse events and response to treatment.
| irAE | All patients, N (%) | PD + SD, N (%) | PR, N (%) | P value |
|---|---|---|---|---|
| None | 48 (49.5) | 37 (77.1) | 11 (22.9) | 1.000 |
| Any grade* | 48 (49.5) | 37 (77.1) | 11 (22.9) | |
| Grade | ||||
| <3 | 90 (92.8) | 72 (80.0) | 18 (20.0) | 0.023 |
| ≥3* | 6 (6.2) | 2 (33.3) | 4 (67.7) | |
*, response was non-evaluable in one patient and was excluded from response analysis. irAE, immune-related adverse event; PD, progressive disease; SD, stable disease; PR, partial response.